Cardiomedics’ patented Graduated Pressure Regimen is the only clinically proven system, published in a peer-reviewed journal, to reduce all cause mortality in Class II, III, and IV Congestive Heart Failure (CHF) patients from 19% to 1.85% and lower hospitalizations by 85.7%. No other ECP manufacturer
has been able to demonstrate results that show any reduction in mortality and hospitalizations in these three classes of CHF patients. This unique and effective approach to patient care illustrates Cardiomedics commitment to improving the quality of life of all cardiac patients. The Graduated Pressure Regimen allows Cardiomedics to lead the way in treating Class IV CHF patients, many of whom improve one to two Classes and enjoy a quality of life once thought lost to them.